- Home
- DGX
as 08-01-2025 4:00pm EST
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | SECAUCUS |
| Market Cap: | 19.8B | IPO Year: | 1996 |
| Target Price: | $185.40 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.35 | EPS Growth: | 12.66 |
| 52 Week Low/High: | $142.86 - $182.38 | Next Earning Date: | 07-22-2025 |
| Revenue: | $10,522,000,000 | Revenue Growth: | 12.58% |
| Revenue Growth (this year): | 10.88% | Revenue Growth (next year): | 3.68% |
Stock Insider Trading Activity of Quest Diagnostics Incorporated (DGX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DELANEY MARK E | DGX | SVP & Chief Commercial Officer | May 12 '25 | Sell | $175.52 | 1,748 | $306,800.22 | 8,372 |
Latest Quest Diagnostics Incorporated News
DGX Breaking Stock News: Dive into DGX Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
Quest Diagnostics Releases 2024 Corporate Responsibility Report
PR Newswire
a month ago
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
Barchart
a month ago
Is Quest Diagnostics Stock Outperforming the Nasdaq?
Investor's Business Daily
a month ago
Quest Diagnostics Stock Trades Near A Buy Zone; Capture Profits With This Long Call Butterfly In Options Trading
PR Newswire
2 months ago
PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership
Zacks
2 months ago
DGX Stock Up on New Blood Test Development Deal With MD Anderson
StockStory
2 months ago
The 5 Most Interesting Analyst Questions From Quest’s Q1 Earnings Call
StockStory
2 months ago
1 Safe-and-Steady Stock to Own for Decades and 2 to Avoid
Compare DGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DGX Quest Diagnostics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.